Cargando…
Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer
Amlodipine is a Ca(2+) channel blocker commonly used to cardiovascular diseases such as hypertension and angina; however, its anticancer effects in lung cancer A549 cells remain unknown. In the present study, we explored the antitumor effects and molecular mechanisms underlying the action of amlodip...
Autores principales: | Fu, Bingjie, Dou, Xiaojing, Zou, Miao, Lu, Hao, Wang, Kaixuan, Liu, Qingxia, Liu, Yao, Wang, Wei, Jin, Meihua, Kong, Dexin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198715/ https://www.ncbi.nlm.nih.gov/pubmed/35721193 http://dx.doi.org/10.3389/fphar.2022.902305 |
Ejemplares similares
-
Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC
por: Wang, Kaixuan, et al.
Publicado: (2023) -
Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo
por: Zhao, Xiaoxia, et al.
Publicado: (2021) -
Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
por: Wang, Yingying, et al.
Publicado: (2020) -
ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC
por: Zhao, Hongbo, et al.
Publicado: (2018) -
Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis
por: Yi, Min, et al.
Publicado: (2023)